Agape ATP raises $23M for green energy push; revenue up, margins down, losses and control risks

Agape ATP Corporation (NASDAQ: ATPC) - Quick take

What's happening: management completed a large equity raise (46,000,000 shares) and deposited $23,000,000 with a third‑party manager (Bi Cheng) to fund future investments. The company is diversifying from health & wellness into green energy, which lifted revenue but compressed margins. At the same time the business remains unprofitable and management discloses material weaknesses in internal controls and a going‑concern risk.

Key facts & figures

* Revenue (Q2 2025): $465,499 vs $313,039 (Q2 2024). Six months 2025: $754,536 vs $631,682 (2024).

* Gross profit (Q2 2025): $208,940 (gross margin ~44.9%) vs $193,561 (~61.8%) in Q2 2024. Six months 2025 gross profit $365,226 (48.4%) vs $396,981 (62.8%).

* Operating expenses (Q2 2025): $845,901 (selling + commissions + G&A). G&A alone (Q2 2025): $767,343.

* Loss from operations (Q2 2025): $(636,961). Net loss (Q2 2025): $(623,246) vs $(432,315) a year earlier. Six months net loss: $(1,336,165) vs $(1,135,410).

* EPS (basic & diluted): Q2 2025 $(0.01) vs Q2 2024 $(0.12). Six months 2025 $(0.04) vs $(0.30) (reflects large share issuance).

* Cash & equivalents (June 30, 2025): $215,973 (down from $2,040,243 at 12/31/24); no time deposits as of 6/30/25.

* Prepayments & deposits (6/30/25): $24,008,789 - includes a $23,000,000 deposit to Bi Cheng Investment Management Limited (unallocated as of report date).

* Total assets: $24,721,175 (12/31/24: $3,240,020). Total liabilities: $1,314,627. Total equity: $23,406,548 (increase driven by $23M stock proceeds and additional paid in capital $34,237,074).

* Shares outstanding (Aug 13, 2025): 50,005,381. Net cash provided by financing (six months): $23,115,678 (primarily proceeds from issuance: $23,000,000).

* Cash flow - operating (6 months): net cash used $(1,948,332); investing: $(23,000,660) (advance for investment); financing: +$23,115,678.

* Concentrations & related parties: one customer ~29.1% of Q2 revenue and ~21.4% of receivables (accounts receivable concentration previously 79.7% at 12/31/24). Major vendor concentration and significant related‑party activity (e.g., other payables - related parties $237,392; CEO borrowings/payables included).

* Controls: management identified material weaknesses - insufficient accounting personnel, no functional internal audit, and weak procedures to evaluate the third‑party manager holding the $23M deposit.

Positive aspects (income statement & balance sheet)

* Revenue growth year‑over‑year: Q2 revenue up ~48.7% and new revenue streams (green energy; skin care) contributed to top‑line growth.

* Company secured $23,000,000 in equity financing (March 2025) which materially increased liquidity on paper and substantially strengthened equity.

* Unrealized holding gains on marketable securities in 2025 contributed modestly to other income ($7,748 Q2).

Negative aspects (income statement & risks)

* Persistent and growing operating losses: Q2 net loss $(623,246); six‑month loss $(1,336,165). Large G&A ($767,343 Q2) is the dominant expense driver.

* Falling gross margin: from ~61.8% (Q2 2024) to ~44.9% (Q2 2025) - green energy revenue has lower margins and pulled overall profitability down.

* Interest income collapsed (Q2 2025 $153 vs Q2 2024 $19,332) reflecting loss of interest‑bearing time deposits; operating cash burn remains significant.

* Material going‑concern uncertainty: management discloses substantial doubt due to recurring losses, negative operating cash flow, and the $23M deposit that is unallocated and of uncertain recovery/return.

* Concentration and related‑party risks: customer/vendor concentration and sizeable related‑party balances and transactions increase operational risk and governance concerns.

* Internal control weaknesses materially raise the risk of accounting or disclosure errors (affects reliability of financials until remediated).

What to watch next

* Status and recoverability/use of the $23,000,000 deposit with Bi Cheng - conversion into revenue‑generating investments or return of funds is mission‑critical.

* Quarterly trends in gross margin and G&A: management must show expense control or margin improvement in green energy/skin care segments to move toward profitability.

* Remediation of internal control weaknesses - hiring qualified finance staff, establishing internal audit, and better third‑party due diligence.

* Cash flows from operations over next 2-4 quarters; any additional financing or covenant terms tied to the $23M deposit.

Bottom line: Agape ATP (NASDAQ: ATPC) has real revenue momentum from new lines (green energy + skin care) and just completed a $23M equity injection, but profitability is deteriorating (lower margins) and the business faces short‑term liquidity/government and counterparty risks because a large unallocated deposit is held by a third party and internal controls are weak. Investors should monitor the outcome of the $23M entrusted investment and management's remediation of control and governance issues.